Novartis AG’s eye-care division Alcon has opened an investigation into allegations that members of its Chinese staff bribed doctors at hundreds of hospitals in China, the second time the company has looked into possible problems at its China operations in as many months.
Subscribe
‘Enforcement 40’ for 2020
Our Sponsors
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn